Gene therapy vectors in the gigadalton (GDa) regime are beyond the range of conventional mass spectrometry. Charge-detection MS overcomes this limitation.
Martin F. Jarrold
Advertisement
Articles by Martin F. Jarrold
Advertisement
Latest Updated Articles
Charge Detection Mass Spectrometry: Analysis of Gene Therapy VectorsSeptember 1st 2022
Advertisement
Advertisement
Trending on LCGC International
1
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
2
A Look at the Major Technical Themes of ASMS 2026
3
Mass Spectrometry Approaches for Investigating Alpha-Synuclein Structural Changes in Neurodegenerative Disease
4
LC-MS Links Gut Metabolites to Anxiety Therapy
5